Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
RAI-refractory DTC
.
Show all posts
Showing posts with label
RAI-refractory DTC
.
Show all posts
Monday, April 27, 2015
Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC
›
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) approved the company's receptor tyrosine kinase inhibi...
›
Home
View web version
